ratiopharm Group
Division of Teva Pharmaceutical Industries Ltd.
www1.ratiopharm.com
Latest From ratiopharm Group
Germany Approves Trilogy Of Switches
German Expert Panel Opposes OTC Ibuprofen/Phenylephrine Combo, Hydrocortisone 1%
Two prescription-to-OTC switch applications rejected by Germany’s Expert Committee for Prescription: preparations containing a combination of ibuprofen and phenylephrine hydrochloride and hydrocortisone 1% for external use.
Distortion And Inflation In Measuring Pharma M&A
Five companies in big pharma’s top 20 have come through mergers in the past 10 years or so that changed them significantly. As measured by standard financial performance parameters, the processes at Takeda and Teva (and to some extent, at Allergan) seem relatively smooth and productive. Those at Pfizer and Merck don’t. But it depends on how you look at the numbers.
EU confirms suspension of 700 products hit by Indian CRO issues
Around 700 generic drugs will no longer be available in Europe from 21 August after the European Commission issued a decision confirming the products' suspension in light of concerns over data manipulation by the Indian CRO GVK Biosciences.
Company Information
- Industry
-
Pharmaceuticals
- Generic Drugs
- OTC, Consumer
- Therapeutic Areas
- Non-Specific
- Alias(es)
- ratiopharm GMBH
- Magnafarma
- Ownership
- Private
- Headquarters
-
Worldwide
-
Europe
-
Western Europe
-
Germany
-
Germany
-
Western Europe
-
Europe
- Parent & Subsidiaries
- Teva Pharmaceutical Industries Ltd.
- Senior Management
- Oliver Windholtz, CEO
- Contact Info
-
ratiopharm Group
Phone: (49) 731 402 02
Graf-Arco-Strasse 3
P.O. Box 3380 Ulm, 89079
Germany
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice